These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27148924)

  • 1. BioThrax and Anthrasil for anthrax.
    Med Lett Drugs Ther; 2016 May; 58(1494):62. PubMed ID: 27148924
    [No Abstract]   [Full Text] [Related]  

  • 2. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
    Rynkiewicz D; Rathkopf M; Sim I; Waytes AT; Hopkins RJ; Giri L; DeMuria D; Ransom J; Quinn J; Nabors GS; Nielsen CJ
    Vaccine; 2011 Aug; 29(37):6313-20. PubMed ID: 21624418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax vaccine begins a new round of tests.
    Marshall E
    Science; 2002 Jan; 295(5554):427-9. PubMed ID: 11799216
    [No Abstract]   [Full Text] [Related]  

  • 4. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
    J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obiltoxaximab (Anthim) for inhalation anthrax.
    Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of mycoplasma contamination in the anthrax vaccine.
    Hart MK; Del Giudice RA; Korch GW
    Emerg Infect Dis; 2002 Jan; 8(1):94-6. PubMed ID: 11840996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.
    Pittman PR; Cavicchia MA; Kingsbury JL; Johnson NA; Barrera-Oro JG; Schmader T; Korman L; Quinn X; Ranadive M
    Vaccine; 2014 Sep; 32(39):5131-9. PubMed ID: 24837771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of new vaccines against Bacillus anthracis.
    Baillie L
    J Appl Microbiol; 2001 Oct; 91(4):609-13. PubMed ID: 11576296
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.
    J Toxicol Clin Toxicol; 2001; 39(1):85-100. PubMed ID: 11327233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress on the vaccine for anthrax].
    Zhan DW; Wang P; Wang LC; Zhang ZS
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from the 2001 anthrax attacks: immunological characteristics.
    Hadler JL
    J Infect Dis; 2007 Jan; 195(2):163-4. PubMed ID: 17191158
    [No Abstract]   [Full Text] [Related]  

  • 13. Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.
    Longstreth J; Skiadopoulos MH; Hopkins RJ
    Expert Rev Vaccines; 2016 Dec; 15(12):1467-1479. PubMed ID: 27792416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology. A binding contract for anthrax.
    Bull JJ; Parrish CR
    Science; 2002 Jul; 297(5579):201-2. PubMed ID: 12114612
    [No Abstract]   [Full Text] [Related]  

  • 16. Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.
    Meaney-Delman D; Zotti ME; Creanga AA; Misegades LK; Wako E; Treadwell TA; Messonnier NE; Jamieson DJ;
    Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24457117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infections by Bacillus anthracis].
    Biederbick W; Fock R; Güttler K; Veit C
    Dtsch Med Wochenschr; 2002 Apr; 127(15):809-14. PubMed ID: 11951140
    [No Abstract]   [Full Text] [Related]  

  • 18. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
    Hendricks KA; Wright ME; Shadomy SV; Bradley JS; Morrow MG; Pavia AT; Rubinstein E; Holty JE; Messonnier NE; Smith TL; Pesik N; Treadwell TA; Bower WA;
    Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24447897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    Wright JG; Quinn CP; Shadomy S; Messonnier N;
    MMWR Recomm Rep; 2010 Jul; 59(RR-6):1-30. PubMed ID: 20651644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.